Live Science on MSNOpinion
From gene therapy breakthroughs to preventable disease outbreaks: The health trends that will shape 2026
Live Science's health channel editor makes predictions about the medical breakthroughs and public health shifts to come in ...
Beam Therapeutics advances base-editing pipeline with risto-cel studies and FDA designations, but no approved products and rising competition loom.
The Indian government has banned oral Nimesulide formulations above 100mg, including tablets and syrups, citing serious liver ...
Corynebacterium glutamicum S9114, a superior strain widely used in glutamic acid industrial production through traditional mutagenesis screening, is ...
Blockchain, nanomedicine, and 3D printing signal a growing emphasis on improving healthcare delivery through innovative ...
Morning Overview on MSN
New CRISPR leap could transform treatment for genetic diseases
Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...
Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...
In one of the rockiest years yet for science, Philadelphia-area researchers still managed to celebrate many wins. Here are five of them.
TheFly published on November 26, 2025, that Chardan kept its buy recommendation on CRISPR Therapeutics AG (NASDAQ:CRSP) while ...
The moa were a group of giant flightless birds that lived in New Zealand. They disappeared from Earth about 600 years ago, ...
Trial data on epcoritamab plus rituximab-lenalidomide, a novel CELMoD agent, late-line CAR-T cell therapy, and selecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results